Quarterly report · Q1

Period2022-07-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥2.2bn2022-07-01 → 2022-09-30Cons.Net sales
Revenue¥9.3bn2021-07-01 → 2022-06-30Cons.Net sales (5-year summary)
Revenue¥2.6bn2021-07-01 → 2021-09-30Cons.Net sales
Operating income¥46m2022-07-01 → 2022-09-30Cons.Operating income
Operating income¥64m2021-07-01 → 2021-09-30Cons.Operating income
Ordinary income¥46m2022-07-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥1.3bn2021-07-01 → 2022-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥110m2021-07-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥46m2022-07-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥109m2021-07-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥14m2022-07-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥810m2021-07-01 → 2022-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥83m2021-07-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥16m2022-07-01 → 2022-09-30Cons.Profit loss
Net income¥86m2021-07-01 → 2021-09-30Cons.Profit loss
Total assets¥7.9bnat 2022-09-30Cons.Assets
Total assets¥8.5bnat 2022-06-30Cons.Assets
Total assets¥7.3bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥1.2bnat 2022-09-30Cons.Liabilities
Total liabilities¥1.6bnat 2022-06-30Cons.Liabilities
Net assets / equity¥6.7bnat 2022-09-30Cons.Net assets
Net assets / equity¥6.8bnat 2022-06-30Cons.Net assets
Net assets / equity¥6.1bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥5.0bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥6.0bnat 2022-06-30Cons.Cash and deposits
EPS (basic)¥0.532022-07-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.952021-07-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥3.162021-07-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio82.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio78.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio81.3%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 45
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30¥600,000
Reconciling Itemsreconcilingrevenue external2022-07-01 → 2022-09-30¥600,000
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥77m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue2022-07-01 → 2022-09-30¥89m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2022-07-01 → 2022-09-30¥89m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2022-07-01 → 2022-09-30−¥13m
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2022-07-01 → 2022-09-30¥1.1bn
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2022-07-01 → 2022-09-30¥1.1bn
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2022-07-01 → 2022-09-30¥282m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue2022-07-01 → 2022-09-30¥732m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue external2022-07-01 → 2022-09-30¥732m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentsegment profit2022-07-01 → 2022-09-30−¥184m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue2022-07-01 → 2022-09-30¥138m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue external2022-07-01 → 2022-09-30¥138m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentsegment profit2022-07-01 → 2022-09-30¥23m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue2022-07-01 → 2022-09-30¥148m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue external2022-07-01 → 2022-09-30¥148m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentsegment profit2022-07-01 → 2022-09-30¥15m
—segment totalrevenue2022-07-01 → 2022-09-30¥2.2bn
—segment totalrevenue external2022-07-01 → 2022-09-30¥2.2bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥123m
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-09-30−¥2m
Reconciling Itemsreconcilingrevenue external2021-07-01 → 2021-09-30¥600,000
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-09-30−¥3m
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥82m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue2021-07-01 → 2021-09-30¥72m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2021-07-01 → 2021-09-30¥72m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2021-07-01 → 2021-09-30−¥18m
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2021-07-01 → 2021-09-30¥1.4bn
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2021-07-01 → 2021-09-30¥1.4bn
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2021-07-01 → 2021-09-30¥316m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue2021-07-01 → 2021-09-30¥805m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue external2021-07-01 → 2021-09-30¥805m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentsegment profit2021-07-01 → 2021-09-30−¥209m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue2021-07-01 → 2021-09-30¥184m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue external2021-07-01 → 2021-09-30¥181m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥3m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentsegment profit2021-07-01 → 2021-09-30¥34m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue2021-07-01 → 2021-09-30¥149m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue external2021-07-01 → 2021-09-30¥149m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentsegment profit2021-07-01 → 2021-09-30¥22m
—segment totalrevenue2021-07-01 → 2021-09-30¥2.6bn
—segment totalrevenue external2021-07-01 → 2021-09-30¥2.6bn
—segment totalrevenue intersegment2021-07-01 → 2021-09-30¥3m
—segment totalsegment profit2021-07-01 → 2021-09-30¥145m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 311
ItemContextValueUnit
Retained earningsPrior1YearInstant2911255000JPY
Retained earningsCurrentQuarterInstant2794206000JPY
Shareholders equityPrior1YearInstant6647798000JPY
Shareholders equityCurrentQuarterInstant6530749000JPY
Non controlling interestsPrior1YearInstant199568000JPY
Non controlling interestsCurrentQuarterInstant201754000JPY
Net assetsPrior1YearInstant6847367000JPY
Net assetsCurrentQuarterInstant6732504000JPY
Liabilities and net assetsPrior1YearInstant8489524000JPY
Liabilities and net assetsCurrentQuarterInstant7889956000JPY
Net salesPrior1YTDDuration2557851000JPY
Net salesCurrentYTDDuration2216881000JPY
Cost of salesPrior1YTDDuration1401003000JPY
Cost of salesCurrentYTDDuration1160778000JPY
Gross profitPrior1YTDDuration1156847000JPY
Gross profitCurrentYTDDuration1056102000JPY
Selling general and administrative expensesPrior1YTDDuration1093324000JPY
Selling general and administrative expensesCurrentYTDDuration1010156000JPY
Operating incomePrior1YTDDuration63523000JPY
Operating incomeCurrentYTDDuration45946000JPY
Interest income noiPrior1YTDDuration22000JPY
Interest income noiCurrentYTDDuration105000JPY
Foreign exchange gains noiPrior1YTDDuration117000JPY
Foreign exchange gains noiCurrentYTDDuration-JPY
Compensation income noiPrior1YTDDuration44738000JPY
Compensation income noiCurrentYTDDuration143000JPY
Other noiPrior1YTDDuration1191000JPY
Other noiCurrentYTDDuration820000JPY
Non operating incomePrior1YTDDuration46069000JPY
Non operating incomeCurrentYTDDuration1069000JPY
Other noePrior1YTDDuration21000JPY
Other noeCurrentYTDDuration535000JPY
Non operating expensesPrior1YTDDuration21000JPY
Non operating expensesCurrentYTDDuration535000JPY
Ordinary incomePrior1YTDDuration109571000JPY
Ordinary incomeCurrentYTDDuration46479000JPY
Impairment loss elPrior1YTDDuration270000JPY
Impairment loss elCurrentYTDDuration-JPY
Extraordinary lossPrior1YTDDuration270000JPY
Extraordinary lossCurrentYTDDuration-JPY
Income before income taxesPrior1YTDDuration109301000JPY
Income before income taxesCurrentYTDDuration46479000JPY
Income taxes currentPrior1YTDDuration47866000JPY
Income taxes currentCurrentYTDDuration30022000JPY
Income taxes deferredPrior1YTDDuration-24807000JPY
Income taxes deferredCurrentYTDDuration529000JPY
Income taxesPrior1YTDDuration23059000JPY
Income taxesCurrentYTDDuration30551000JPY
Profit lossPrior1YTDDuration86242000JPY
Profit lossCurrentYTDDuration15928000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-06-30pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-06-30pass
statement vs summary · total assetsconsolidated 2022-09-30pass